New interest in Berkshire? Which Chinese platform is looking to avoid US China tensions and a COVID 19 breakthrough for a drug maker
Your Money with Michelle Martin13 Huhti 2021

New interest in Berkshire? Which Chinese platform is looking to avoid US China tensions and a COVID 19 breakthrough for a drug maker

On Market View Minute, Michelle Martin discusses what was behind the surge in Berkshire Hathaway, Trip.com plans a secondary listing and Regeneron's COVID-19 breakthrough.

See omnystudio.com/listener for privacy information.

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
mimmit-sijoittaa
psykopodiaa-podcast
rss-rahapodi
rss-rahamania
pomojen-suusta
ostan-asuntoja-podcast
juristipodi
rss-myyntikoulu
rss-draivi
herrasmieshakkerit
rahapuhetta
sijoitusovi-podcast
rss-lahtijat
rss-seuraava-potilas
bakkari-tarinoita-tapahtumien-takahuoneista
rss-h-asselmoilanen
rss-startup-ministerio
rss-bisnesta-bebeja
rss-turha-edes-yrittaa